Rapid improvement in post-stroke pain and additional clinical improvements documented following the INR’s patented anti-TNF treatment, 17 years after stroke.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be needed for optimal benefit. Anti-TNF treatment for this indication is off-label. The method of local anti-TNF treatment utilized for these patients is a patented invention of the INR. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311 and Australian patent 758523, all assigned to TACT IP LLC.